CymitQuimica logo

CAS 11051-90-4

:

(3β,11α,12β,14β)-11-(Acétyloxy)-3-[(O-6-désoxy-3-O-méthyl-β-D-allopyranosyl-(1→4)-O-2,6-didésoxy-3-O-méthyl-β-D-arabino-hexopyranosyl-(1→4)-2,6-didésoxy-3-O-méthyl-β-D-ribo-hexopyranosyl)oxy]-14-hydroxy-12-[(1-oxo-3-phényl-2-propén-1-yl)oxy]pregnan-20-one

Description :
La substance chimique portant le nom "(3β,11α,12β,14β)-11-(Acétyloxy)-3-[(O-6-désoxy-3-O-méthyl-β-D-allopyranosyl-(1→4)-O-2,6-didésoxy-3-O-méthyl-β-D-arabino-hexopyranosyl-(1→4)-2,6-didésoxy-3-O-méthyl-β-D-ribo-hexopyranosyl)oxy]-14-hydroxy-12-[(1-oxo-3-phényl-2-propén-1-yl)oxy]pregnan-20-one" est une molécule organique complexe caractérisée par son squelette stéroïdien, typique des pregnanes. Ce composé présente plusieurs groupes fonctionnels, y compris acétoxy, hydroxy et liaisons glycosidiques, indiquant son activité biologique potentielle et son interaction avec divers systèmes biologiques. La présence de motifs sucrés suggère qu'il pourrait présenter des propriétés liées à la glycosylation, ce qui peut influencer la solubilité, la stabilité et la bioactivité. Le groupe phényle attaché à la molécule laisse entrevoir de possibles interactions aromatiques, qui pourraient jouer un rôle dans ses effets pharmacologiques. Dans l'ensemble, la structure complexe de ce composé suggère qu'il pourrait avoir des implications significatives en chimie médicinale, en particulier dans le développement d'agents thérapeutiques. Son numéro CAS, 11051-90-4, permet une identification précise dans les bases de données chimiques et la littérature.
Formule :C53H78O17
InChI :InChI=1S/C53H78O17/c1-27(54)35-21-23-53(59)36-18-17-33-24-34(20-22-51(33,6)42(36)47(66-31(5)55)49(52(35,53)7)68-39(56)19-16-32-14-12-11-13-15-32)67-40-25-37(60-8)45(29(3)63-40)69-41-26-38(61-9)46(30(4)64-41)70-50-44(58)48(62-10)43(57)28(2)65-50/h11-16,19,28-30,33-38,40-50,57-59H,17-18,20-26H2,1-10H3
Code InChI :InChIKey=ZKWQLHAAXWFVPF-UHFFFAOYSA-N
SMILES :O(C(C)=O)C1C2C(C3(O)C(C)(C1OC(C=CC4=CC=CC=C4)=O)C(C(C)=O)CC3)CCC5C2(C)CCC(OC6CC(OC)C(OC7CC(OC)C(OC8C(O)C(OC)C(O)C(C)O8)C(C)O7)C(C)O6)C5
Synonymes :
  • (3β,11α,12β,14β)-11-(Acetyloxy)-3-[(O-6-deoxy-3-O-methyl-β-<span class="text-smallcaps">D</smallcap>-allopyranosyl-(1→4)-O-2,6-dideoxy-3-O-methyl-β-<smallcap>D</smallcap>-arabino-hexopyranosyl-(1→4)-2,6-dideoxy-3-O-methyl-β-<smallcap>D</span>-ribo-hexopyranosyl)oxy]-14-hydroxy-12-[(1-oxo-3-phenyl-2-propen-1-yl)oxy]pregnan-20-one
  • (3β,8xi,9xi,11α,12β,14β)-11-(acetyloxy)-3-{[6-deoxy-3-O-methyl-β-D-allopyranosyl-(1->4)-2,6-dideoxy-3-O-methyl-β-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-3-O-methyl-β-D-ribo-hexopyranosyl]oxy}-14-hydroxy-20-oxopregnan-12-yl (2E)-3-phenylprop-2-enoate
  • Condurango glycoside A
  • Pregnan-20-one, 11-(acetyloxy)-3-[(O-6-deoxy-3-O-methyl-β-<span class="text-smallcaps">D</smallcap>-allopyranosyl-(1→4)-O-2,6-dideoxy-3-O-methyl-β-<smallcap>D</smallcap>-arabino-hexopyranosyl-(1→4)-2,6-dideoxy-3-O-methyl-β-<smallcap>D</span>-ribo-hexopyranosyl)oxy]-14-hydroxy-12-[(1-oxo-3-phenyl-2-propen-1-yl)oxy]-, (3β,11α,12β,14β)-
  • Pregnan-20-one, 11-(acetyloxy)-3-[(O-6-deoxy-3-O-methyl-β-<span class="text-smallcaps">D</smallcap>-allopyranosyl-(1→4)-O-2,6-dideoxy-3-O-methyl-β-<smallcap>D</smallcap>-arabino-hexopyranosyl-(1→4)-2,6-dideoxy-3-O-methyl-β-<smallcap>D</span>-ribo-hexopyranosyl)oxy]-14-hydroxy-12-[(1-oxo-3-phenyl-2-propenyl)oxy]-, (3β,11α,12β,14β)-
  • (3β,11α,12β,14β)-11-(Acetyloxy)-3-[(O-6-deoxy-3-O-methyl-β-D-allopyranosyl-(1→4)-O-2,6-dideoxy-3-O-methyl-β-D-arabino-hexopyranosyl-(1→4)-2,6-dideoxy-3-O-methyl-β-D-ribo-hexopyranosyl)oxy]-14-hydroxy-12-[(1-oxo-3-phenyl-2-propen-1-yl)oxy]pregnan-20-one
  • Pregnan-20-one, 11-(acetyloxy)-3-[(O-6-deoxy-3-O-methyl-β-D-allopyranosyl-(1→4)-O-2,6-dideoxy-3-O-methyl-β-D-arabino-hexopyranosyl-(1→4)-2,6-dideoxy-3-O-methyl-β-D-ribo-hexopyranosyl)oxy]-14-hydroxy-12-[(1-oxo-3-phenyl-2-propen-1-yl)oxy]-, (3β,11α,12β,14β)-
  • Pregnan-20-one, 11-(acetyloxy)-3-[(O-6-deoxy-3-O-methyl-β-D-allopyranosyl-(1→4)-O-2,6-dideoxy-3-O-methyl-β-D-arabino-hexopyranosyl-(1→4)-2,6-dideoxy-3-O-methyl-β-D-ribo-hexopyranosyl)oxy]-14-hydroxy-12-[(1-oxo-3-phenyl-2-propenyl)oxy]-, (3β,11α,12β,14β)-
Trier par

Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
3 produits concernés.
  • Condurango glycoside A

    CAS :
    <p>Condurango glycoside A activates p53, induces ROS generation, up-regulates p53 expression, and triggers apoptosis as well as premature senescence associated</p>
    Formule :C53H78O17
    Couleur et forme :Solid
    Masse moléculaire :987.18
  • Condurango glycoside a

    CAS :
    Natural glycoside
    Formule :C53H78O17
    Degré de pureté :≥ 90.0 % (HPLC)
    Couleur et forme :Powder
    Masse moléculaire :987.18

    Ref: 5G-83941

    10mg
    407,00€
    50mg
    1.770,00€
    250mg
    8.356,00€
    500mg
    15.728,00€
    1000mg
    29.490,00€
  • Condurangoglykosid A

    CAS :
    <p>Condurangoglykosid A is a natural product and an anticancer drug that has shown to be effective in the treatment of prostate cancer. This drug inhibits the growth of tumour cells by preventing necrosis factor from binding to the cell membrane, which prevents the release of cytochrome C from mitochondria. Condurangoglykosid A also protects liver cells from damage and death by inhibiting toxins that are released into the body during cancer treatment. Condurangoglykosid A also inhibits tumor growth by blocking nuclear factor kappa-light-chain-enhancer (NFκB) activation in cancer cells. This drug can be administered orally and has been shown to be safe for human use. It has been observed that Condurangoglykosid A may have an antitumor effect on cervical cancer cells, but this has not been confirmed yet.</p>
    Formule :C53H78O17
    Degré de pureté :Min. 95%
    Masse moléculaire :987.2 g/mol

    Ref: 3D-LAA05190

    5mg
    863,00€
    10mg
    1.085,00€
    25mg
    1.952,00€